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Abstract
Connexin43 (Cx43) is a component of gap junctions and is involved in intercel-
lular signaling following injury to tissues. The carboxyl terminus of Cx43 binds to
the PDZ2 domain of ZO-1 in order to form gap junction plaques and connect to the
cytoskeleton. A biomimetic peptide known as αCT-1, replicating the last 9 amino
acids found in the carboxyl terminus of CX43, has been shown to improve wound
healing by preferentially binding to the PDZ2 domain of ZO-1. A possible mecha-
nism for its action is through the Epithelial-Mesenchymal Transformation (EMT).
Scratch assays were performed on rat bone marrow stromal cells treated with the
peptide and were then analyzed using qPCR, western blotting, confocal microscopy,
and live cell imaging. The gene expression analysis showed up-regulation of F11r
and Krt19 and down-regulation of Mmp3. Protein expression analysis indicated an
increase in Krt19 and the complete absence of Snai2 in the αCT-1 treated samples.
Confocal microscopy suggested increased actin remodeling, increased size of Cx43 gap
junctions, and reduction and localization of Mmp3 to the nucleus. Live cell imaging
showed an increase in migration for the first seven hours followed by a breakdown in
cell to cell contact. The genes and proteins chosen in this study did not indicate the
changes of EMT; however, migration and morphology of the cells were similar to that
of cells undergoing EMT. This study provides a beginning look into the mechanism
of αCT-1 and will aid in its future development as a treatment for enhancing healing
capabilities.
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Chapter 1
Introduction
Wound healing is a process that requires numerous signaling mechanisms to co-
ordinate actions between multiple cells. One mechanism for the spread of signals
related to a wound is through protein structures known as gap junctions. Some sig-
nals are beneficial to wound healing, yet the spread of apoptotic signals through gap
junctions can increase tissue damage (Lin et al. 1998). The natural mechanism to
prevent tissue damage through gap junction signaling, is to close and reduce gap
junctions (Peters et al. 1993). In particular, it has been shown that down-regulation
of Connexin43 (Cx43) at a wound site reduces inflammation and improves migra-
tion and proliferation (Mori et al. 2006). In tissues dependent upon gap junctions
for healthy functions such as the heart and brain, this loss of signaling can lead to
further damage. Biomimetic peptides such as αCT-1 have been shown to limit tissue
damage and improve healing after injury, yet the exact mechanism of action has not
been determined.
1.1 Gap Junctions
Gap junctions are one of many membrane proteins found in cells. Gap junctions
create channels between the cytoplasm of adjacent cells that allow for the passage of
molecules less than 1 kDa in size (Alexander and Goldberg 2003). They are critical
to tissue function in the heart, neurons, and smooth muscle. Gap junctions are made
of subunit proteins called connexins. Cx43 is one of the most commonly expressed
connexin proteins, existing in many different tissues throughout the body (Beyer,
1
Figure 1.1: General structure of connexins, connexons, and gap junction plaques
(Ruiz 2006).
Paul, and Goodenough 1987; Solan and Lampe 2009). It is essential for normal heart
function as it allows for the transmission of action potentials, and in a mouse model
its deletion resulted in death (Reaume et al. 1995). It consist of four transmembrane
regions (M1-M4), two extracellular loops (EL1-EL2), a cytoplasmic loop (CL), a short
amino terminus (NT), and a long carboxyl terminus (Cx43CT) (Milks et al. 1988;
Kumar and Gilula 1996). Connexins combine to form hexameric connexons which
then combine to create gap junctions, but there are numerous regulatory steps that
control the formation and coupling of gap junctions.
The entire process of assembly and transportation is intricate and regulated by
numerous signals (for review see Segretain and Falk 2004). Briefly, the connexins
are transcribed in the endoplasmic reticulum (ER) then assembled into connexons
upon leaving the ER (Musil and Goodenough 1993). These can be composed of one
type of connexin or multiple types (He et al. 1999). After transport through the
Golgi Apparatus, the connexons are transported in vesicles along microtubules, then
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integrated into the cell membrane. In the membrane, connexons can exist as either
hemichannels or gap junctions. Hemichannels allow molecules to flow in and out of
the cell through the pore. Hemichannels can also align at 30 degree offsets (Perkins,
Goodenough, and Sosinsky 1998) and dock with others in adjacent cells to create gap
junctions through which small molecules can flow between cells (Friend and Gilula
1972; Unger et al. 1999; Goodenough and Paul 2009). These gap junctions typically
form aggregates known as plaques.
In order for Cx43 connexons to leave the Golgi apparatus and migrate to the
membrane, they must be transported by a membrane-associated guanylate kinase
(MAGUK) protein known as Zonula Occludens-1 (ZO-1) (Wu, Tsai, and Chung 2003).
ZO-1 escorts the Cx43 connexon to the edge of the plaque, and then inserts it into
the plaque where it will couple to form a gap junction (Rhett, Jourdan, and Gourdie
2011). This region surrounding plaques with a high concentration of ZO-1 bound
hemichannels is known as the perinexus (Palatinus, Rhett, and Gourdie 2012). ZO-1
is also known to disassemble the plaques, and shRNA silencing of ZO-1 results in
a lack of plaque disassembly and increased intracellular Cx43 due to inability to be
transported to the membrane (Akoyev and Takemoto 2007). The carboxyl terminus
of Cx43 (Cx43CT) interacts with the PDZ2 domain of ZO-1 (Toyofuku et al. 1998;
Giepmans and Moolenaar 1998) which alters the function of Cx43 as well as serving
as a scaffold to connect Cx43 to the cytoskeleton and other proteins (Fanning, Ma,
and Anderson 2002).
1.2 Connexin43 Carboxyl Terminus
The Cx43CT is the most studied region of the protein as it contains numerous
regulation sites which can be modified or bind to various proteins (Giepmans 2004).
It is capable of dimerizing with other Cx43CTs (Sorgen et al. 2004a), binding to the
cytoplasmic loop to block the pore due to changes in pH (Duffy et al. 2002) and
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voltage (Moreno 2002) and even binding to nearby cytoplasmic loops (Stergiopoulos
et al. 1999). Other proteins shown to bind to the Cx43CT include Akt (Park et al.
2009), CCN3 (Fu et al. 2004), v-Src (Lin et al. 2001), c-Src (Sorgen et al. 2004b),
and P2Y1 (Scemes 2008).
The carboxyl terminus of Cx43 consists of 150 residues, starting at the end of
the M4 region around residue 230 and culminating at residue 382 as shown in Figure
1.2. In these 150 residues there are 21 serine residues and 1 tyrosine residue that
can be phosphorylated. The effect of phosphorylation on the Cx43CT is still being
investigated, but it has been shown that the Cx43CT typically exists in at least three
different states of phosphorylation: P0, P1, and P2. Upon initial translation, Cx43 is
in the P0 state with no phosphorylation. Upon reaching the membrane it is typically
changed to the P1 (Ser365) then the P2 (Ser325, Ser328, Ser330) state and becomes
a functional gap junction (Solan and Lampe 2009).
In particular there are several phosphorylation sites crucial to the functioning
of Cx43 gap junctions during injury. Under ischemic conditions in the heart, Cx43
uncouples and migrates away from intercalated disks. Phoshporylation at Ser368 by
protein kinase C (PKC) has been shown to reduce Cx43 gap junction conductivity
(Ek-Vitorin et al. 2006; Bao, Reuss, and Altenberg 2004) and increase Cx43 gap
junctions disassembly by ZO-1 (Akoyev and Takemoto 2007). This phosphorylation
can be prevented by phosphorylation at Ser365 which is normally phosphorylated in
healthy tissue (Solan et al. 2007).
1.3 αCT-1 Peptide
Recent research has focused on the use of biomimetic peptides that interfere with
the function of Connexin43 due to its roles in tissue damage and wound healing (Wang
et al. 2007; Nakano et al. 2008). While studying the interaction of ZO-1 with Cx43
gap junctions in HeLa cells, it was observed that Green Fluorescent Protein (GFP)
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Figure 1.2: Structures of Cx43 protein and αCT-1 peptide (Hunter et al. 2005).
tagged Cx43CT resulted in an increase in the size of gap junctions by interfering with
the ZO-1/Cx43 interaction. Upon introducing a synthetic peptide sequence (αCT-1)
which mimics a portion of the Cx43CT, the the experiment was repeated yielding
a similar outcome (Hunter et al. 2005). The αCT-1 peptide contains the last nine
amino acids of Cx43CT, an antennopedia region to aid in cellular uptake, and biotin
for easy detection. The peptide works by binding to the PDZ2 domain of ZO-1
which is where Cx43CT normally binds. It may also bind to the other proteins that
bind to the Cx43CT or to the cytoplasmic loop of Cx43 (Rhett et al. 2008; Bouvier
et al. 2009). αCT-1 has been shown to accelerate wound closure rates while also
reducing scar tissue formation in cutaneous injuries in porcine models (Ghatnekar
et al. 2009) as well as limiting gap junction remodeling and improving heart function
following cryo-injury (O’Quinn et al. 2011). The peptide also increases PKC related
phosphorylation of Cx43CT-Ser368 after injury (Palatinus, Rhett, and Gourdie 2011).
1.4 Bone Marrow Stromal Cells
Bone marrow stromal cells (BMSCs; sometimes referred to as bone mesenchymal
stem cells) were chosen as the tissue culture model for this study. BMSCs have been
shown to be multipotent stem cells and can differentiate into numerous cell types
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(Pittenger 1999; Jiang et al. 2002) and have been shown to have a significant role
in wound healing (Bucala et al. 1994; Seppanen et al. 2013). They have also been
shown to be easily transfected and capable of expressing proteins for extended periods
(Hurwitz et al. 1997; Krebsbach et al. 2003; Aluigi et al. 2006).
1.5 Epithelial-Mesenchymal Transformation
Due to the widespread effects of αCT-1 on wound healing and the many protein
interactions of Cx43CT, it has been hypothesized that a cell signaling pathway known
as the Epithelial-Mesenchymal Transformation (EMT) may be involved in the mech-
anism of αCT-1. EMT is a group of pathways involved in the transformation of cells
from an epithelial phenotype to a mesenchymal phenotype. In addition to a change
in gene and protein expression, there is a decrease in cell to cell junctions, adoption
of a spindle morphology, and increased migratory capabilities. EMT is classified into
three types: type 1-embryogenesis and organ development, type 2-wound healing,
and type 3-cancer growth and metastasis (Kalluri and Weinberg 2009). Type 2 EMT
is necessary in wound healing as the cells adjacent to the wound need to move into
the gaps left by the wound. Epithelial cells will undergo EMT, lose their polarity,
dissociate from neighboring cells, and migrate into the wound area.
In preliminary studies in our lab, we used a PCR Super Array (Qiagen) with EMT
genes to study how rat BMSCs reacted to αCT-1. These results, found in Appendix A,
showed up-regulation of the genes for Keratin19 (Krt19), Matrix metalloproteinase-3
(Mmp3), F11r (Junctional Adhesion Molecule-A, JAM-A), and several others. These
genes were chosen for further study in a more detailed experiment. In addition, Snai2
was chosen due to its role as a transcription factor involved in initializing EMT (Sav-
agner, Yamada, and Thiery 1997; Bolos 2002), as well as Cx43 and ZO-1 due to
their central role in the action of the peptide. In vitro scratch assays were performed
on rat BMSCs to determine whether these genes are altered, and to show that the
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EMT pathway is a possible mechanism for the increased healing caused by the αCT-1
peptide.
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Chapter 2
Methods
2.1 Cell Isolation and Expansion
The following procedures were performed according to the animal experimentation
guidelines set forth by the Institutional Animal Care and Use Committee (IACUC),
of the University of South Carolina School of Medicine. Rat BMSCs were isolated
from the bone marrow of rats (Sprague Dawley). The rats were sacrificed by dry
ice asphyxiation. The femur and tibia were removed and cleaned of any remaining
soft tissues. The interior of the bones were flushed with primary culture media
(Dulbecco’s Modified Eagle Medium supplemented with 5% fetal bovine serum, 50
µg/mL gentamicin, and 250 ng/mL amphotericin B) into 50 mL conical tube. The
tube was centrifuged at 800 rpm for 8 minutes. After removing the supernatant, the
cells were resuspended in primary culture media. The cells were placed in T75 flasks
(Greiner), and placed in an incubator set at 5% CO2 and 37◦C for one week. Media
was replaced as needed, usually after 1-2 weeks or when the cells had attached to
the flask. Once the cells were at 90% confluency, they were passaged by rinsing with
Moscona’s solution (in mM: 136.8 NaCl, 28.6 KCl, 11.9 NaHCO3, 9.4 glucose, 0.08
NaH2PO4, pH 7.4), trypsinizing with 0.05% trypsin/0.1% EDTA and plating again
in two T75 flasks. If necessary cells were frozen in liquid nitrogen. Cells to be used for
analysis were thawed and then passaged and placed into 6-well plates (RNA analysis),
12-well plates (protein analysis), 6-well plates on coverslips (confocal microscopy), or
MatTek dishes (live cell imaging).
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2.2 Gene Expression Analysis
Scratch Assay
Once the cells had grown to become 90% confluent the scratch assay was per-
formed. The media was removed from the wells, and the wells were rinsed with
Moscona’s Solution. Two parallel scratches, each 2cm long and 1cm apart, were
made near the center of the well using a 20µL pipette tip (ART). The wells were
rinsed once more with Moscona’s Solution. Four time points were taken for both
αCT-1 and control samples: an unscratched sample (time=0), one hour, two hour,
and three hour.
A solution made of αCT-1 dissolved in Moscona’s solution to a concentration of
100µM. 20µL of this solution was placed on each scratch of the test samples, and for
the control samples 20µL of Moscona’s solution was placed on the scratches. The
dishes were placed in the incubator for 30 minutes then primary culture media was
added to each well. The RNA was extracted immediately for the no scratch samples
and at one, two, and three hours later for the other time points.
RNA Extraction
To extract the RNA, the wells were rinsed with Moscona’s solution. Then, using a
RNeasy Mini Kit (Qiagen), 350 mL of the RLT buffer and 5µL of β-mercaptoethanol
were added to each well. The cells were agitated and mixed with the pipette tip. The
solution was then transferred to a 1.5mL centrifuge tube and frozen at -20◦C.
After thawing the RNA extract, the RNA lysate was transferred to a RNeasy spin
column. The extraction was performed as described by the manufacturers instructions
described as follows.
• Add 500µL of 70% ethanol to the RLT lysate and mix by pipetting
• Transfer solution to spin column and centrifuge for 15 seconds
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• Add 700µL of Buffer RW1 to the spin column and spin for 15 seconds
• Add 500µL of Buffer RPE to the spin column and spin for 15 seconds
• Add 500µL of Buffer RPE to the spin column and spin for 2 minutes
• Add 25µL of RNase-free water to spin column and spin for 1 minutes and collect
flow-through
• Repeat prior step to collect remainder of RNA
The collected RNA was frozen and stored at -20◦C.
RNA Analysis & cDNA Synthesis
The RNA concentration and RNA Integrity Number (RIN) were obtained by using
a mRNA Nano Chip and running it on the 2100 Bioanalyzer (Agilent). The results
can be found in Appendix C. An iScript cDNA Kit (Bio-Rad) was used to transcribe
cDNA from the RNA. For each sample, 1µg of RNA was added to a mixture of 8µL
of iScript 5x Reaction mix, 2µL of Reverse Transcriptase, and RNase-Free water for
a total volume of 80µL. The mixture was run in a iCycler Thermal Cycler (Bio-Rad)
for 5 minutes at 25◦C, 30 minutes at 42◦C, 5 minutes at 85◦C, and then stored at 4◦C.
qPCR
In order to quantify the gene expression, qPCR was carried out using a CFX Con-
nect (Bio-Rad, Hercules, CA). Primers (Integrated DNA Technologies) were designed
using Primer BLAST (National Institute of Health). The primers were designed to
have a melt temperature near 60±2◦C. A two step protocol was used with an an-
nealing temperature of 58◦C and a melt temperature of 95◦. A melt curve was used
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Table 2.1: Primers used in qPCR
mRNA Forward Primer Reverse Primer Product
Size
ARBP CGACCTGGAAGTCCAACTAC ATCTGCTGCATCTGCTTG 109
Cx43 TCAGCCTCCAAGGAGTTCCACCAAC GCACTGACAGCCACACCTTCCC 159
F11r TGTTCCCAGCGGAGTTGCGG CCGAACCCTTGCCTTGCACC 111
Krt19 GCACTGTGGCAGAGATAGAGG TGAGCTGATACTCCTGGT 132
Mmp3 GGAGGCAGCAAAGAACCCGCT GGGTAGGATGAGCACACAGCCG 111
Snai2 CCAGGCTAGGAAATCGTTCA TGGGTGAACCTGGAAAGGTA 107
ZO-1 CCATCTTTGGACCGATTGCTG TAATGCCCGAGCTCCGATG 123
starting at 70◦ to check for any primer dimers or multiple transcripts. Primer efficien-
cies were determined using serial dilutions of rat tongue cDNA. In each well, 6.25ng
of cDNA (1µL) was loaded into 19µL of master-mix containing primers and SSoAd-
vanced SYBR Green Supermix (Bio-Rad, Hercules, CA). qBase+ (Bio-Gazelle) was
used to process the data using the Pfaﬄ Method (Pfaﬄ 2001) by normalizing the
target transcript relative quantities to acidic ribosomal phosphoprotein P0 (ARBP)
relative quantities. Analysis of variance (ANOVA) was used to determine which
transcripts were affected by the time and treatment. Bonferroni post testing was
performed to compare time point pairs of each gene.
2.3 Protein Analysis
Scratch Assay
For the protein isolation, plated as described above except using 12-well plates in
order to reduce biological noise from cells that were not near the scratch. Samples
were agitated in the presence of 350µL of T-Per Buffer (Thermo Scientific) with the
addition of 1% HALT Protease Inhibitor (Thermo Scientific). The protein samples
were centrifuged and the supernatant was collected to remove any cellular debris.
Samples from three wells were combined and concentrated using a 10 kDa Microcon
Concentrator (Milipore) to increase the protein concentration by reducing the vol-
ume of the sample. A Bradford Coomassie Assay was performed to determine the
concentration of each sample.
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Western Blotting
Western blotting was performed on the treated and untreated cells in order to
determine the effect of αCT-1 treatment resulting in any changes in the protein con-
centration of the EMT markers following injury. Bio-Rad Criterion Gels 4-15% with
12+2 45µL wells were used. For each sample, 20µg of protein was dissolved in 20µL
of water, then mixed in a 1:1 ratio with Laemmli Buffer with 5% β-mercaptoethanol.
The sample solutions were then denatured by heating in a water bath at 70◦C for 10
minutes. The samples were then loaded into the gel alongside 20µL of Dual Color
Precision Protein Standard (Bio-Rad). The gels were run at 125V for 1-1.5 hours,
until the loading dye had almost reached the bottom of the gel. The protein was
transferred to supported nitrocellulose membranes using a Criterion Blotter (Bio-
Rad) at 100V for 45 minutes.
The blots were then rinsed with Phosphate Buffer Solution (PBS) with 0.05%
Tween20 3 times for 5 minutes. The blots were blocked for an hour in 5% Blotting
Grade Milk Blocker (Bio-Rad) dissolved in PBS. The blots were probed with the
with primary antibodies in 1:1000 (except for 1:500 for Krt19) dilutions in 5% milk
blocker in PBS-Tween overnight at 4◦. After rinsing in PBS-Tween, the blots were
probed with horseradish peroxidase conjugated secondary antibodies for 1 hour in
the same dilution and buffer as the primary antibodies. The blots were then sprayed
with HyGlo ECL (Denville Scientific) and agitated for 1 minute. Images of the blots
were captured using an autoradiography cassette and HyGlo Film (Denville Scientific)
with exposure times between 8 seconds and 3 minutes. Densitometry was performed
using ImageJ (NIH) and ERK-1 as a normalizing protein.
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Table 2.2: Antibodies used in western blotting and confocal microscopy
Protein Host Manufacturer Catalog # Size (kDa)
Erk-1 Mouse BD 610030 42-44
Cx43 Mouse Millipore MAB3067 43
ZO-1 Mouse Developmental Studies Hybridoma Bank R26.4C 225
Krt19 Mouse Novus NBII 42238 40-44
Snai2 Rabbit Santa Cruz sc-15391 34
Mmp3 Rabbit Santa Cruz sc-6839-r 53
JAM-A Rabbit Santa Cruz sc-25629 32
anti-Mouse HRP Goat Invitrogen M30107 N/A
anti-Rabbit HRP Goat Invitrogen 656120 N/A
anti-Mouse 546 Goat Life Technologies A-11035 N/A
anti-Rabbit 546 Goat Life Technologies A-11030 N/A
2.4 Confocal Microscopy
Scratch Assay
In order to determine the cellular localization of the various proteins following
scratch and treatment, confocal micrscopy was performed. The cells were grown on
coverslips placed in 6-well plates. The cells were rinsed with Moscona’s Solution then
scratched. The scratches were made in a direction so that the most confluent cells
would be subjected to the scratch. Each coverslip was scratched twice using a P20
pipette tip. The cells were rinsed again, then the peptide or control solutions were
added to each scratch. After incubating for 30 minutes, the cells were rinsed again,
then media was added. At each time point, the cells were rinsed and then fixed using
2% paraformaldehyde in PBS for 10 minutes. The cells were then rinsed in 0.01M
Glycine in PBS twice for 15 minutes before being permeabilized with 0.1% Triton
X-100/0.01M Glycine/PBS.
Fluorescence Antibody Staining
The coverslips were rinsed between each of the following steps by rinsing in PBS
for five minutes three times, except after the initial blocking step. The coverslips
were blocked in 5% Bovine Serum Albumin in PBS for one hour. They were then
probed with the primary antibodies in 5% BSA/PBS (1:200) for one hour. They were
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then stained with Alexa Fluor 546 IgG(H+L) highly cross adsorbed (Life Technolo-
gies) secondary antibodies in 5%BSA/PBS (1:250) for one hour. Next, F-Actin was
stained with Alexa Fluor 488 Phalloidin (Life Technologies) in PBS (1:200). Finally,
the nuclei were stained with 4’,6-Diamidino-2-Phenylindole (DAPI) (1:2500). The
coverslips were mounted on slides using 1,4-diazabicyclo[2.2.2]octane (DABCO).
Confocal Microscopy Imaging
The images were captured using a Zeiss LSM 510 microscope. The lasers used
were the 405nm, Argon 488nm, and HeNe 543nm. All images were taken using a 63X
oil immersion objective. Multi-track image collection was used in order to prevent
cross-talk between channels by imaging one channel at a time with filters to block non-
specific emissions. Emission from some fluorophores can excite fluorophores of longer
wavelengths leading to some channels showing fluorescence from another fluorophore.
2.5 Live Cell Imaging
Scratch Assay
Cells were grown in 35mmMatTek Dishes (MatTek) until they were 90% confluent.
After being rinsed with Moscona’s Solution, cells were scratched then rinsed again.
Cells were only scratched once since the microscope is not equipped with a automated
stage and thus can only image one area per frame. 100 µL of 100µM αCT-1 dissolved
in primary culture media was added to the dish and allowed to incubate for 30
minutes. Then 1 mL of media was added to the dish to sustain the cells during
imaging.
Image Acquisition
Images were acquired using a Zeiss Axiovert 200M Inverted Microscope. A 10X
phase contrast objective was used in combination with a HAL 100 light source. The
14
microscope chamber was set 37◦C and 5% CO2 and allowed to preheat for several
hours to prevent focal drift. Images were collected every 6 minutes over 24 hours
using AxioVision software.
Image Analysis
In order to measure migration, several MATLAB functions were written to auto-
mate this process and can be found in Appendix D. Each image was subtracted from
next image in the time series, to remove any static objects and leave only portions
where cells moved. A Wiener filter was used to remove additional noise from the
subtracted images. The filtered image was thresholded to a black and white image.
Any objects near the top of the image were removed to avoid measure cells from the
opposite side of the scratch. A dilation morphological filter was used to fill in some
of the smaller gaps left over. Objects smaller than 5000 pixels were removed from
the image to remove random debris from detection. Then, using the regionprops
function, total area of all of the objects on the screen was measured.
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Chapter 3
Results
3.1 Gene Expression
Previous in vivo studies have shown that the αCT-1 renders an effect on cells
within 2 hours of application (Ghatnekar et al. 2009). Time points at 1, 2, and 3
hours were chosen in order to study the effect on mRNA transcripts around the 2
hour window. For each time point there were three samples taken from different
culture wells. Analysis of the qPCR data shows that the time from scratch and
treatment with αCT-1 changed the expression of several genes. Cx43 expression
showed no difference between control and αCT-1 samples, but both samples showed
equal reduction in expression with time. In contrast, expression of F11r increased
over time in both samples peaking at 2 hours, but αCT-1 samples were consistently
greater with significant increases at 2 and 3 hours. Krt19 followed a similar pattern
of increasing expression with time, and significant increases in the αCT-1 samples at
2 and 3 hours. Mmp3 showed little variation with the exception of the two hour time
point during which the αCT-1 sample showed a significant decrease before increasing
back above the control levels. Snai2 failed to show any significant differences between
αCT-1 and control, but showed a steady decrease with time in both samples. Finally,
ZO-1 remained stable throughout the 3 hour time period with only minor fluctuations.
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Figure 3.1: Results of qPCR analysis showing effects of αCT-1 on gene expression.
Bars represent standard error. Single asterisks indicate p<0.05, double asterisks
indicate p<0.01 (n=3).
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Table 3.1: ANOVA of qPCR Results
Gene Time Treatment
Cx43 *<0.001 0.082
F11r *0.001 *<0.001
Krt19 *<0.001 *<0.001
Mmp3 0.354 0.873
Snai2 *<0.001 0.629
ZO-1 0.424 0.346
Table of p-values for the ANOVA performed qPCR expression values. P-value<0.05
is considered significant and indicated with an asterisk.
3.2 Protein Expression
In order to determine whether the changes in gene expression carried over into
protein expression, western blotting was performed at the same time points. Due to
various problems with protein extraction and antibodies, only one blot was imaged for
each protein. Extracellular-signal-regulated kinase 1 (ERK-1) is stably expressed and
was used to determine normalization factors for densitometry as shown in Appendix
B. It showed consistent bands confirming that it was not affected by the peptide.
For Cx43, αCT-1 treated samples showed higher expression in the no scratch and one
hour samples, yet lower expression in the two and three hour samples. Cx43 showed
two distinct bands, possibly the P0 and P1/P2 states, but due to the wide range of
proteins being analyzed the gel resolution for such close bands was minimal. The
results for Krt19 were similar to the gene expression results as the αCT-1 samples
were greater for all points except the three hour sample. Yet the protein analysis
of JAM-A (corresponding to gene F11r), showed little relation with control samples
showing higher expression the no scratch and three hour samples, no difference at one
hour, and a slight increase in αCT-1 at two hours. Likewise, Mmp3 control samples
showed higher expression in the no scratch and 1 hour sample which inverted in the
two and three hour samples with the three hour control showing almost no expression.
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Figure 3.2: Images of western blots for each protein.
Snai2 had the most noticeable results with a complete absence of protein in all of the
αCT-1 samples. Finally, ZO-1 showed slight increase in αCT-1 in the no scratch and
three hour sample, with no difference at one hour, and a large increase at 2 hours.
It should be noted that western blotting often lacks the sensitivity required to
discern the small changes in protein expression that may occur in this experiment
without running numerous replicates The faint bands for ZO-1 can be attributed to
larger proteins being more difficult to transfer. Many of the bands showed minimal
changes between samples. Despite having faint bands, Snai2 is the only protein that
was completely down-regulated due to the αCT-1 treatment.
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3.3 Confocal Analysis
Confocal microscopy for Cx43 showed increased gap junction size as mentioned
in Hunter et al. 2005. The location of Cx43 within the cells showed no pattern
or orientation relative to the scratch border. Few gap junctions are visible in the
images and are sporadic. JAM-A appeared in small amounts throughout the cells.
It typically appeared in small clusters, but it was difficult to discern any consistent
localization results. However, Krt19 yielded no information as it appeared to be
equally dispersed throughout the cells in all samples. Images for Mmp3 showed
differences in localization between control and αCT-1 treated cells. Control samples
showed protein scattered throughout the cells evenly, yet in the αCT-1 samples the
protein localized to the nucleus and the area surrounding the nucleus. Snai2 tended
to aggregate in and near the nucleus, but this localization was repeated across all
samples. ZO-1 also showed a lack of information; it appeared spread throughout the
cell equally.
Looking at the the F-actin staining, it appeared that the αCT-1 had an effect on
the structure of actin. The F-actin filaments in the αCT-1 cells appear to be thinner
and more linear compared to the disperse and overlapping structure of the untreated
cells. Also, in the αCT-1 samples the actin filaments appear to not attach to the cell
membrane compared to the control samples. These changes appear to be greatest
two hours after the scratch.
3.4 Cell Migration
To investigate the effect of αCT-1 on cell migration and movement, live cell imag-
ing was used to image the cells with a temporal resolution of 6 minutes over 24 hours.
Cell migration showed clear differences between the control samples and the peptide
treated samples. Looking at the total area occupied by cells in the image, the control
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Figure 3.3: Confocal microscopy images of Cx43 stained cells. Blue-nucleus (DAPI),
Green-F-Actin (Phalloidin), Red-Cx43 (Cy-3). Scratches are located on the top bor-
der of each image except for the no scratch (NS) samples. Smaller gap junctions
plaques can be seen in the αCT-1 treated samples. Scale bar=20µm.
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Figure 3.4: Confocal microscopy images of Mmp3 stained cells. Blue-nucleus (DAPI),
Green-F-Actin (Phalloidin), Red-Mmp3 (Cy-3). Scratches located on the top border
of each image except for the no scratch (NS) samples. Scale bar=20µm.
.
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Figure 3.5: Confocal microscopy images of just actin in two hour samples. Scale
bar=20µm.
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samples filled in more of the scratch void than the peptide samples. As shown in
Figure 3.7, all samples start moving at roughly the same rate, yet at around 7 hours
the peptide treated cells slow down and cease advancing. This is also shown in the
images in Figure 3.6. The αCT-1 treated cells begin to separate from each other
and begin to ruﬄe their edges while not moving, seemingly losing all directionality of
movement. The cells on the edge of the scratch void move forwards at first, but the
cells behind them do not follow leading to large gaps between cells. In contrast, the
control cells maintain their cell-cell contacts and move together as a monolayer. Cells
at the front of the scratch edge maintain coordinated migration towards the scratch
void, and cells behind the leading edge continue to move behind the leading cells
preventing large gaps from forming. The control cells also showed large lamellipodia
with some cells reach across others to enter the scratch void. These were completely
absent in the αCT-1 treated cells, as they only showed shorter protrusions that did
not lead to cell movement.
24
Figure 3.6: Images showing control and peptide treated cells migrating across the
scratch void at time intervals of 8 hours over a 24 hour period. Scale bar=100µm
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Figure 3.7: Cell migration analysis showing the relative area, normalized against
initial area, of cells migrating across scratch over a 24 hour period.
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Chapter 4
Discussion
Previous work done has demonstrated the healing properties of αCT-1 but has
focused on the tissue level effects (Ghatnekar et al. 2009; Soder et al. 2009) or the
Cx43/ZO-1 interaction (Hunter et al. 2005; Hunter and Gourdie 2008). Due to these
wound healing effects, it is likely that the extent of the mechanism of αCT-1 extends
beyond its effects on Cx43 and ZO-1. In order to identify other possible changes
induced by αCT-1, the EMT pathway was chosen due to its role in wound healing.
In EMT, proteins related to tight junctions (JAM-A) and the cytoskeleton (Krt19)
are normally down-regulated to allow for cell migration. Looking at just the gene ex-
pression of the no scratch samples, Krt19 is increased with αCT-1 treatment and
Mmp3 is decreased. At the two hour time point, there was the greatest number
of significant changes in gene expression with F11r, Krt19, and Mmp3 all showing
significance. Snai2 has been shown to be an effective transcriptional factor for in-
ducing the EMT pathway (Savagner, Yamada, and Thiery 1997; Bolos 2002). Snai2
showed a steady decline in gene expression with time, yet this was not matched by
western blot analysis. There was a complete absence of Snai2 protein in the αCT-1
samples, differing from the expected up-regulation normally shown in EMT. Mmp3
is normally up-regulated in EMT to break down the extracellular matrix. Confocal
microscopy showed more evenly distributed Mmp3 in the control samples compared
to the αCT-1 samples, and the western blotting showed similar results in protein
quantity. The western blot and confocal microscopy results for Mmp3 may not be
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accurate since it is a secreted protein. Zymography would have to be carried out to
measure extracellular Mmp3 levels.
The live cell imaging results showed every characteristic expected of EMT: cells
adopting spindle morphologies, accelerated movement, and the breakdown of cell-cell
contacts. The cessation of movement at around seven hours is unusual as the cells
continue to ruﬄe the membranes, but they lack any orientation in their movements.
There are two possible explanations for this lack of movement. First, the cells may
still be capable of moving but are unable to either control the direction of movement
or can no longer detect the driving signal of movement. Second, the cells are not
migration towards anything, but instead are moving away from other cells. It appears
that once cells on the leading edge move enough to lose contact, they cease to move.
The changes in F-actin may also support EMT. During the process of EMT,
the actin structures have been shown to be remodeled as they lose connections to
membrane proteins and must make connections elsewhere (Yilmaz and Christofori
2009). This event may stem from αCT-1 disrupting the ZO-1/Cx43 interaction. ZO-
1 acts a scaffold between the membrane proteins and actin by providing binding
areas for both proteins (González-Mariscal, Betanzos, and Avila-Flores 2000; Rhett,
Jourdan, and Gourdie 2011). The removal of ZO-1 from gap junctions may reduce
the available binding locations for actin to connect with the membrane. This may
explain the decreased structure and spindle morphology shown in the treated samples
in live cell imaging. With the decreased actin structure, the cell may be forced to
adopt a more morphology requiring less support.
The data suggests that there are two opposing activities occurring within the cells;
the gene and protein expression indicating no relation to EMT, but the movement
and structure of the cell indicate EMT has occurred. There are several possibilities
for these mixed results. The EMT pathway contains numerous different genes and
proteins. It is possible that the genes chosen in this study are not part of the EMT
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pathway triggered by αCT-1. These cells are also already mesenchymal cells. The
EMT pathways can achieve little overall change to these cells; the only change to
be expected would be a shift from stationary mesenchymal cells to more mobile and
invasive cells.
Research on αCT-1 has so far only shown the effects on wound healing, Cx43, and
gap junctions. The down regulation of Cx43 with time that occurs between treated
and untreated samples is to be expected as it has been shown that Cx43 expression
is reduced following injury (Mori et al. 2006). Yet this change in expression does
not match with the protein results, albeit possibly due to limited sample size for the
western blot analysis. The confocal images of Cx43 show the expected increase in
gap junction size, but this alone does not seem to be enough to explain the change
in the cell movement. Due to the peptide acting on the PDZ2 of ZO-1, the effect
on the cell can stretch well beyond altering gap junction activity. The effect seen
with JAM-A may be caused by the altered ZO-1. JAM-A has been shown to bind to
the PDZ3 of ZO-1 and aid in the formation of adherens-like junctions (Morris et al.
2006). ZO-1 also has a homologous protein, ZO-2, that can bind to the PDZ2 domain
to aid in the formation of scaffolding structure attached to tight junctions (Fanning
et al. 1998; Itoh et al. 1999). The PDZ2 domain has also shown to be necessary for
the proper formation of bands of tight junctions located at the perimeter of epithelial
cells (Rodgers et al. 2012).
The interference in the normal activity of ZO-1 may explain the changes in gene
expression. The αCT-1 peptide alone may be enough to induce morphological and
migratory changes that occur in EMT, yet EMT is normally induced by growth factors
or other factors altering transcription directly. The gene and protein expression seen
may have been a result in a reaction to this EMT-like behavior. The cell may try
to restore itself back to its normal state by reducing EMT related gene expression,
which would explain the lack of Snai2 protein, up-regulation of Krt19 and JAM-A,
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and down-regulation of Mmp3. With the altered activity of ZO-1 the changes in
expression may not materialize due to changes in protein interactions.
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Chapter 5
Conclusion
This study shows that EMT may not be an affected pathway of rat BMSCs when
treated with αCT-1, yet it demonstrates the extent of its effects on gene expression
and cell movement. These effects go well beyond the immediate changes caused by
the Cx43/ZO-1 interaction. Further research will be required to understand how
Cx43 and ZO-1 can effect these studied genes and proteins.
The genes in this study were limited to the EMT pathway, but there may be
other genes affected by αCT-1. With the recent discovery of new protein interactions
with the Cx43CT such as Akt (Park et al. 2009), CCN3 (Fu et al. 2004), v-Src (Lin
et al. 2001), c-Src (Sorgen et al. 2004b), and P2Y1 (Scemes 2008), it is necessary to
determine if any of these proteins may be disrupted by αCT-1 either through blocking
interactions or direct binding. One approach for discovering the affected proteins, is
to continue work on immunoprecipitation assays similar to those previously done in
Hunter et al. 2005. It is also important to look at the role that the Cx43CT has on
DNA synthesis (Doble et al. 2004) and cell proliferation (Dang, Doble, and Kardami
2003).
Further research will be necessary to determine the full extent of effects that
αCT-1 has on BMSCs and even other cell types. Epithelial cell types should be
similarly tested as they may show a more significant change along the EMT pathway.
In addition, wound model studies can be performed to study delivery of the peptide.
BMSCs have been shown to improve healing when implanted into damaged tissue as
well as being capable of expressing transfected genes and naturally assisting in wound
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healing (Hurwitz et al. 1997; Studeny et al. 2002; Aluigi et al. 2006; Shen et al. 2006;
Rong et al. 2008). Due to the short time of effect of the peptide, this could serve
as a way of extending the release for longer periods of time. Studying the combined
effect on an in vivo animal model using this method may prove to be a promising
long term treatment to accelerate wound healing and reduce scar tissue. There are
many possible uses and applications of the peptide, and with further understanding
of the its mechanism of action, it may prove to be a powerful tool in the treatment
of injury and disease.
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Appendix A
EMT PCR Super Array Results
Table A.1: Genes in EMT Array
Ahnak Col5a2 Fgfr2 Ilk Mmp2 Ptk2 Sox10 Tgfb3 Wnt5a
Akt1 Ctgf Fkbp1a Itga5 Mmp3 Ptp4a1 Sparc Timp1 Wnt5b
Bmp7 Ctnnb1 Fn1 Itgav Mmp9 Rac1 Spp1 Tmeff1 Zeb1
Cald1 Dsc2 Foxc2 Itgb1 Msn Rgs2 Stat3 Tmem132a Zeb2
Camk2n1 Dsp Fzd7 Jag1 Nodal Serpine1 Steap1 Tspan13 Rplp1
Cav2 Egfr Gng11 Krt14 Notch1 Sip1 Tcf3 Twist1 Hprt1
Cdh1 Erbb3 Gsc Krt19 Ocln Smad2 Tcf4 Vcan Rpl13a
Cdh2 Esr1 Gsk3b Krt7 Pdgfrb Snai1 Tfpi2 Vim Ldha
Col1a2 F11r Igfbp4 Map1b Plek2 Snai2 Tgfb1 Vps13a Actb
Col3a1 Fgfbp1 Il1rn Mitf Ppp3r1 Snai3 Tgfb2 Wnt11
Table A.2: EMT Array Trial 1
Up-regulated Down-regulated
Gene Fold Change Gene Fold Change
Jag1 2.0028 Nodal -2.3102
Tgfb2 2.1765 Il1rn -2.5456
Mmp3 2.2377
Dsp 2.7359
Krt14 2.9938
Esr1 3.2989
F11r 4.0897
Krt19 15.9115
Table A.3: EMT Array Trial 2
Up-regulated Down-regulated
Gene Fold Change Gene Fold Change
Sox10 2.1258 None -
Krt19 19.4002
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Appendix B
Protein Densitometry
Figure B.1: Densitometry analysis of all proteins normalized against ERK-1. n=1.
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Appendix C
Bioanalyzer Results
Table C.1: RNA concentration and RIN
Treatment Time Sample RIN Concentration (ng/µL)
Control NS 1 9.5 48
Control NS 2 9.6 51
Control NS 3 9.6 54
Control 1 hr 1 9.5 55
Control 1 hr 2 9.7 60
Control 1 hr 3 9.5 52
Control 2 hr 1 9.3 76
Control 2 hr 2 9.6 70
Control 2 hr 3 9.5 59
Control 3 hr 1 9.5 76
Control 3 hr 2 9.6 67
Control 3 hr 3 9.8 64
αCT-1 NS 1 9.8 41
αCT-1 NS 2 9.7 42
αCT-1 NS 3 9.6 37
αCT-1 1 hr 1 9.6 50
αCT-1 1 hr 2 9.6 37
αCT-1 1 hr 3 9.7 34
αCT-1 2 hr 1 9.9 65
αCT-1 2 hr 2 9.5 44
αCT-1 2 hr 3 9.8 36
αCT-1 3 hr 1 9.8 42
αCT-1 3 hr 2 9.9 42
αCT-1 3 hr 3 9.6 33
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Appendix D
MATLAB Image Processing Code
D.1 Function: importimages
1 function [ importedimages , width , height , ImagesImported ,
F i l eT i f ]= importimages ( skipimage )
2 %% Import Images
3
4 F i l eT i f=uiget f i l e ( ’ ∗ . t i f ’ ) ;
5 InfoImage=im f i n f o ( F i l eT i f ) ;
6 width=InfoImage (1 ) .Width ;
7 he ight=InfoImage (1 ) . Height ;
8 NumberImages=length ( InfoImage ) ;
9 counter=0;
10 i f skipimage==0
11 importedimages=zeros ( height , width , NumberImages , ’ u int8 ’ ) ;
12 t ic
13 x=0;
14 for i =1:NumberImages
15 x=x+1;
16 importedimages ( : , : , x )=imread ( F i l eT i f , ’ Index ’ , i ) ;
17 end
18 t=toc ;
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19 ImagesImported=x ;
20 t ;
21 else
22 importedimages=zeros ( height , width , NumberImages/ skipimage
+1, ’ u int8 ’ ) ;
23 t ic
24 x=0;
25 for i =1: skipimage : NumberImages
26 x=x+1;
27 importedimages ( : , : , x )=imread ( F i l eT i f , ’ Index ’ , i ) ;
28 end
29 ImagesImported=x ;
30 t=toc ;
31 t ;
32 end
33 end
D.2 Function: areameasure
1 function [ outputimage , data , area , movieframe ]=areameasure ;
2
3 input=importimages (0 ) ;
4
5 %below va l u e s can be ad ju s t ed based on image
6 v e r t i c a l l i m i t =250;
7 sma l l o b j e c t s i z e =5000;
8 th r e sho ld =3.75;
9 di sk1=2;
43
10 di sk2=5;
11
12 %s t a r t o f ana l y s i s
13 [ he ight , width , frames ]= s ize ( input ) ;
14 data=zeros ( 1 , 4 ) ;
15 s t=s t r e l ( ’ d i sk ’ , d i sk1 ) ;
16 s t2=s t r e l ( ’ d i sk ’ , d i sk2 ) ;
17 Area=zeros (239) ;
18 Centroid=zeros (239 ,2 ) ;
19 over lay image=zeros ( height , width , 3 , frames ) ;
20 for i i =1:( frames−1)
21 d i f f=imabsd i f f ( input ( : , : , i i ) , input ( : , : , i i +1) ) ;
22 d i f f r e du c ed=wiener2 ( d i f f ) ;
23 bwimage=d i f f r educed>thre sho ld ;
24 d i l a t e=imd i l a t e ( bwimage , s t ) ;
25 openimage=bwareaopen ( d i l a t e , sma l l o b j e c t s i z e ) ;
26 outputimage ( : , : , i i )=imd i l a t e ( openimage , s t2 ) ;
27 for kk=1: v e r t i c a l l i m i t
28 outputimage (kk , : , i i )=0;
29 end
30 bwdata=l o g i c a l ( outputimage ( : , : , i i ) ) ;
31 r eg iondata=reg ionprops ( bwdata , ’ Area ’ , ’ Centroid ’ ) ;
32 [ s t r u c t s i z e , blank ]= s ize ( r eg iondata ) ;
33 area ( i i , 1 ) =0;
34 for j j =1: s t r u c t s i z e
35 [ spot , blank2 ]= s ize ( data ) ;
36 temparea=reg iondata ( j j , 1 ) . Area ;
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37 data ( spot+1, 1)=reg iondata ( j j , 1 ) . Area ;
38 data ( spot+1, 2)=reg iondata ( j j , 1 ) . Centroid (1 , 1 ) ;
39 data ( spot+1, 3)=reg iondata ( j j , 1 ) . Centroid (1 , 2 ) ;
40 data ( spot+1, 4)=i i ;
41 area ( i i , 1 )=area ( i i , 1 )+temparea ;
42 end
43 boundary=bwperim ( outputimage ( : , : , i i ) , 8 ) ;
44 overlayimagetemp=imover lay ( input ( : , : , i i ) , boundary , [ 0 1
0 ] ) ;
45 movieframe ( i i )=im2frame ( overlayimagetemp ) ;
46 end
47 end
D.3 Function: writemovie
1 function writemovie (moviedata , f i l ename )
2
3 writerObj=VideoWriter ( f i l ename ) ;
4 writerObj . FrameRate=10;
5 open ( writerObj ) ;
6 for i i =1:239
7 writeVideo ( writerObj , moviedata ( i i ) ) ;
8 end
9 close ( wr i terObj ) ;
10 end
45
